Open Access
Volume 20, Number 2, March-April 2013
Page(s) 88 - 92
Section Dossier : La place des lipides dans l’alimentation
Published online 15 March 2013
  • Amieva H, Le Goff M, Millet X, et al. Prodromal Alzheimer’s disease: Successive emergence of the clinical symptoms. Ann Neurol 2008 ; 64 : 492–498. [CrossRef] [PubMed] [Google Scholar]
  • Baker LD, Cross DJ, Minoshima S, Belongia D, Watson GS, Craft S. Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early Type 2 diabetes. Arch Neurol 2011 ; 68 : 51–57. [CrossRef] [PubMed] [Google Scholar]
  • Barberger-Gateau P, Raffaitin C, Letenneur L, et al. Dietary patterns and risk of dementia: the Three-City cohort study. Neurology 2007 ; 69 : 1921–1930. [CrossRef] [PubMed] [Google Scholar]
  • Barberger-Gateau P, Samieri C, Allès B, Féart C. Could nutrition prevent the onset of dementia? Current evidence from epidemiological and intervention studies. Neurodegener Dis Manag 2012 ; 2 : 305–314. [Google Scholar]
  • Barberger Gateau P. PUFAs and risk of cognitive decline or dementia: epidemiological data. OCL 2007 ; 14 : 198–201. [Google Scholar]
  • Barberger Gateau P, Feart C, Samieri C. Mediterranean diet and cognitive decline: what role for omega-3 polyunsaturated fatty acids? OCL 2011 ; 18 : 224–227. [EDP Sciences] [Google Scholar]
  • Barberger Gateau P, Samieri C, Feart C, Plourde M. Dietary omega 3 polyunsaturated fatty acids and Alzheimer’s disease: Interaction with apolipoprotein E genotype. Curr Alzheimer Res 2011 ; 8 : 479–491. [CrossRef] [PubMed] [Google Scholar]
  • Cunnane S, Nugent S, Roy M, et al. Brain fuel metabolism, aging, and Alzheimer’s disease. Nutrition 2011 ; 27 : 3–20. [CrossRef] [PubMed] [Google Scholar]
  • Cunnane SC, Plourde M, Pifferi F, Bégin M, Féart C, Barberger-Gateau P. Fish, docosahexaenoic acid and Alzheimer’s disease. Prog Lipid Res 2009 ; 48 : 239–256. [CrossRef] [PubMed] [Google Scholar]
  • Dangour AD, Andreeva VA, Sydenham E, Uauy R. Omega 3 fatty acids and cognitive health in older people. Br J Nutr 2012 ; 107 (Suppl. 2) : S152-8–8. [CrossRef] [PubMed] [Google Scholar]
  • De Lorgeril M, Renaud S, Mamelle N, et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994 ; 343 : 1454–1459. [CrossRef] [PubMed] [Google Scholar]
  • Feart C, Alles B, Merle B, Samieri C, Barberger-Gateau P. Adherence to a Mediterranean diet and energy, macro-, and micronutrient intakes in older persons. J Physiol Biochem 2012 ; 68 : 691–700. [CrossRef] [PubMed] [Google Scholar]
  • Feart C, Jutand MA, Larrieu S, et al. Energy, macronutrient and fatty acid intake of French elderly community dwellers and association with socio-demographic characteristics : data from the Bordeaux sample of the Three-City Study. Br J Nutr 2007 ; 98 : 1046–1057. [CrossRef] [PubMed] [Google Scholar]
  • Feart C, Samieri C, Barberger-Gateau P. Mediterranean diet and cognitive function in older adults. Curr Opin Clin Nutr Metab Care 2010 ; 13 : 14–18. [CrossRef] [PubMed] [Google Scholar]
  • Jack JR CR, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol 2010 ; 9 : 119–128. [CrossRef] [PubMed] [Google Scholar]
  • Mamelak M. Sporadic Alzheimer’s disease: the starving brain. J Alzheimers Dis 2012 ; 31 : 459–474. [CrossRef] [PubMed] [Google Scholar]
  • Mazereeuw G, Lanctot KL, Chau SA, Swardfager W, Herrmann N. Effects of omega-3 fatty acids on cognitive performance: a meta-analysis. Neurobiol Aging 2012 ; 33 : 1482.e17-29. [CrossRef] [PubMed] [Google Scholar]
  • Plourde M, Vohl M-C, Vandal M, Couture P, Lemieux S, Cunnane SC. Plasma n-3 fatty acid response to an n-3 fatty acid supplement is modulated by apoE 4 but not by the common PPAR-alpha L162V polymorphism in men. Br J Nutr 2009 ; 102 : 1121–1124. [CrossRef] [PubMed] [Google Scholar]
  • Profenno LA, Porsteinsson AP, Faraone SV. Meta-analysis of Alzheimer’s disease risk with obesity, diabetes, and related disorders. Biol Psychiatry 2010 ; 67 : 505–512. [CrossRef] [PubMed] [Google Scholar]
  • Quinn JF, Raman R, Thomas RG, et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: A randomized trial. JAMA 2010 ; 304 : 1903–1911. [CrossRef] [PubMed] [Google Scholar]
  • Ramaroson H, Helmer C, Barberger-Gateau P, Letenneur L, Dartigues JF. Prévalence de la démence et de la maladie d’Alzheimer chez les personnes de 75 ans et plus : données réactualisées de la cohorte PAQUID. Rev Neurol 2003 ; 159 : 405–411. [Google Scholar]
  • Ritchie K, Artero S, Touchon J. Classification criteria for mild cognitive impairment: a population-based validation study. Neurology 2001 ; 56 : 37–42. [CrossRef] [PubMed] [Google Scholar]
  • Samieri C, Maillard P, Crivello F, et al. Plasma long-chain omega-3 fatty acids and atrophy of the medial temporal lobe. Neurology 2012 ; 79 : 642–650. [CrossRef] [PubMed] [Google Scholar]
  • Scheltens P, Kamphuis PJGH, Verhey FRJ, et al. Efficacy of a medical food in mild Alzheimer’s disease: A randomized, controlled trial. Alzheimers Dement 2010 ; 6(1–10) : e1. [Google Scholar]
  • Scheltens P, Twisk JW, Blesa R, et al. Efficacy of souvenaid in mild Alzheimer’s disease: results from a randomized, controlled trial. J Alzheimers Dis 2012 ; 31 : 225–236. [CrossRef] [PubMed] [Google Scholar]
  • Sydenham E, Dangour AD, Lim WS. Omega 3 fatty acid for the prevention of cognitive decline and dementia. Cochrane Database Syst Rev 2012 ; 6 : CD005379. [Google Scholar]
  • Viswanathan A, Rocca WA, Tzourio C. Vascular risk factors and dementia: How to move forward? Neurology 2009 ; 72 : 368–374. [CrossRef] [PubMed] [Google Scholar]
  • Yurko-Mauro K, Mccarthy D, Rom D, et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement 2010 ; 6 : 456–464. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.